Suma Krishnan's Net Worth

$323 Million

Estimate Recalculated Sep 13, 2024 09:46PM EST

Who is Suma Krishnan

Suma Krishnan has an estimated net worth of $323 Million. This is based on reported shares across multiple companies, which include NEW RIVER PHARMACEUTICALS INC, Krystal Biotech, Inc., and INTREXON CORP.

SEC CIK

Suma Krishnan's CIK is 0001298711

Past Insider Trading and Trends

2006 was Suma Krishnan's most active year for acquiring shares with 7 total transactions. Suma Krishnan's most active month to acquire stocks was the month of January. 2023 was Suma Krishnan's most active year for disposing of shares, totalling 25 transactions. Suma Krishnan's most active month to dispose stocks was the month of November. 2017 saw Suma Krishnan paying a total of $1,000,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2006 Suma Krishnan cashed out on 396,800 shares for a total of $9,294,129.04, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEW RIVER PHARMACEUTICALS INC

Vice President, Product Dev.
Updated Jan 31, 2007
Form 4
298.20K
Jan 31, 2007
298.20K
Grant
Jan 25
Form 4
-66.67%
-90.00K
$25.58
-$4.24M
Nov 13, 2006
46.00K
Sale
Nov 09 - Nov 10
Form 4
-22.30%
-63.90K
$30.33
-$2.34M
Oct 26, 2006
607.10K
Options
Oct 25
Form 4
-18.18%
-30.00K
$16.58
-$758.04K
May 19, 2006
136.00K
Sale
ScheduledMay 18
Form 4
-31.58%
-30.00K
$16.06
-$888.24K
Mar 22, 2006
66.00K
Sale
ScheduledMar 20
Form 4
-36.95%
-100.00K
$16.11
-$2.82M
Feb 15, 2006
201.64K
Sale
Feb 13 - Feb 14
Form 4
319.50K
Jan 23, 2006
319.50K
Grant
Jan 19
Form 4
-9.52%
-5.00K
$26.92
-$251.72K
Nov 22, 2005
48.00K
Sale
ScheduledNov 22
Form 4
-56.27%
-53.16K
$21.87
-$2.06M
Sep 13, 2005
59.81K
Sale
ScheduledSep 09
Form 4
17.43%
8.16K
$22.14
-$230.90K
Sep 06, 2005
73.47K
Sell-Options
ScheduledSep 01 - Sep 06
Form 4
-21.28%
-5.00K
$36.95
-$184.75K
Aug 23, 2005
19.00K
Sale
ScheduledAug 19
Form 4
-9.18%
-11.00K
$16.25
-$302.50K
Jun 17, 2005
132.31K
Sale
Jun 15
Form 4
319.50K
Mar 31, 2005
319.50K
Grant
Mar 29
Form 4
$2.50
$40.00K
Feb 28, 2005
65.50K
Options
Feb 25
Form 4
150.50K
$8.00
$4.00K
Aug 11, 2004
158.00K
Purchase
Aug 10
Form 3
Aug 03, 2004
7.50K
Showing 16 results

Krystal Biotech, Inc.

President, R&D
Updated Sep 13, 2024
Form 4
-1.61%
-50.00K
$197.77
-$9.89M
Sep 13, 2024
3.20M
Sale
ScheduledSep 12
Form 4
-1.58%
-50.00K
$175.77
-$8.79M
Jun 11, 2024
3.25M
Sale
ScheduledJun 11
Form 4
-1.56%
-50.00K
$170.96
-$8.55M
Mar 11, 2024
3.30M
Sale
ScheduledMar 11
Form 4
1.50%
48.24K
$163.08
-$1.51M
Mar 01, 2024
3.41M
Options
Feb 28 - Feb 29
Form 4
-0.15%
-2.35K
$157.00
-$369.42K
Feb 28, 2024
3.35M
Tax
Feb 26
Form 4
-1.53%
-50.00K
$105.67
-$5.28M
Dec 12, 2023
3.35M
Sale
ScheduledDec 11
Form 4
-1.51%
-50.00K
$127.23
-$6.36M
Sep 12, 2023
3.40M
Sale
Sep 11
Form 4
-1.49%
-50.00K
$116.20
-$5.81M
Jun 02, 2023
3.45M
Sale
May 31
Form 4
-1.47%
-50.00K
$87.65
-$4.38M
Apr 18, 2023
3.50M
Sale
Apr 17
Form 4
2.50%
41.94K
$78.46
-$239.85K
Feb 28, 2023
3.60M
Grant
Feb 26 - Feb 28
Form 4
-1.44%
-50.00K
$80.79
-$4.04M
Jan 19, 2023
3.56M
Sale
ScheduledJan 17 - Jan 18
Form 4
-0.22%
-7.69K
$80.09
-$615.53K
Jan 05, 2023
3.61M
Sale
ScheduledJan 04
Form 4
-0.56%
-19.42K
$80.35
-$1.56M
Jan 03, 2023
3.61M
Sale
ScheduledDec 29 - Jan 03
Form 4
-0.60%
-21.10K
$80.10
-$1.69M
Dec 20, 2022
3.63M
Sale
ScheduledDec 16
Form 4
0.00%
-4.00
$80.01
-$320.04
Nov 28, 2022
3.65M
Sale
ScheduledNov 23
Form 4
-0.05%
-1.79K
$80.05
-$143.20K
Nov 10, 2022
3.65M
Sale
ScheduledNov 08
Form 4
-1.40%
-50.00K
$81.18
-$4.06M
Aug 09, 2022
3.66M
Sale
ScheduledAug 05
Form 4
2.66%
46.72K
$62.50
-$205.12K
Mar 01, 2022
3.76M
Grant
Feb 26 - Feb 28
Form 4
-66.67%
-100.00K
$70.50
-$7.05M
Dec 14, 2021
3.70M
Sale
Dec 10
Form 4
3.87%
71.00K
Mar 02, 2021
3.95M
Grant
Feb 26
Form 4
-2.65%
-50.00K
$46.37
-$2.32M
Sep 17, 2020
3.83M
Sale
ScheduledSep 15 - Sep 17
Form 4
-2.58%
-50.00K
$43.50
-$2.17M
Jun 17, 2020
3.88M
Sale
ScheduledJun 15
Form 4
-0.79%
-15.40K
$40.49
-$623.41K
Mar 18, 2020
3.98M
Sale
ScheduledMar 16 - Mar 18
Form 4
-2.50%
-50.00K
$62.04
-$3.10M
Dec 18, 2019
4.05M
Sale
ScheduledDec 16 - Dec 18
Form 4
1.26%
25.00K
$20.00
$500.00K
Oct 22, 2018
4.15M
Purchase
Oct 18
Form 4
1.28%
25.00K
$11.02
$275.61K
Jun 07, 2018
4.10M
Purchase
Jun 05 - Jun 06
Form 4
0.84%
16.21K
Jun 05, 2018
4.08M
Acquisition
Jun 01
Form 4
5.14%
100.00K
$10.00
$1.00M
Sep 25, 2017
3.98M
Purchase
Sep 22
Form 3/A
Sep 25, 2017
Form 3
Sep 19, 2017
3.78M
Showing 30 results

INTREXON CORP

SVP--Product Development
Updated Feb 01, 2016
Form 4
$6.88
$201.68K
Feb 01, 2016
677.27K
Options
Jan 28 - Jan 29
Form 4
-33.23%
-20.90K
$35.66
-$745.37K
Dec 04, 2015
84.00K
Sale
Dec 02 - Dec 04
Form 4
$7.12
$598.08K
May 20, 2015
678.04K
Options
May 18
Form 4
20.90K
$14.21
$297.02K
May 13, 2014
20.90K
Purchase
May 09
Form 4
300.00K
Mar 24, 2014
385.71K
Grant
Mar 20
Form 3
Aug 07, 2013
Showing 6 results